LIPID MAPS

LM_ID	Common Name	Systematic Name	Species Shorthand	Formula	Mass
LMFA04010398	ent-4-A4-NeuroP	(R,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010399	4-A4-NeuroP	(S,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010400	ent-4,7-diepi-4-A4-NeuroP	(S,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010401	7-epi-4-A4-NeuroP	(S,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010402	ent-4-epi-4-A4-NeuroP	(S,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010403	7-epi-7-A4-NeuroP	(R,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010404	ent-10-epi-7-A4-NeuroP	(R,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010405	7,10-diepi-7-A4-NeuroP	(R,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010406	ent-7-A4-NeuroP	(R,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010407	7-A4-NeuroP	(S,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010408	ent-7,10-diepi-7-A4-NeuroP	(S,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010409	10-epi-7-A4-NeuroP	(S,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010410	ent-7-epi-7-A4-NeuroP	(S,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010411	10-epi-10-A4-NeuroP	(R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010412	ent-13-epi-10-A4-NeuroP	(R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010413	10,13-diepi-10-A4-NeuroP	(R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010414	ent-10-A4-NeuroP	(R,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010415	10-A4-NeuroP	(S,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010416	ent-10,13-diepi-10-A4-NeuroP	(S,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010417	13-epi-10-A4-NeuroP	(S,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010418	ent-10-epi-10-A4-NeuroP	(S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010419	11-epi-11-A4-NeuroP	3-((1R,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010420	ent-4-epi-11-A4-NeuroP	3-((1R,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010421	4,11-diepi-11-A4-NeuroP	3-((1S,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010422	ent-11-A4-NeuroP	3-((1S,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010423	11-A4-NeuroP	3-((1R,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010424	ent-4,11-diepi-11-A4-NeuroP	3-((1R,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010425	4-epi-11-A4-NeuroP	3-((1S,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010426	ent-11-epi-11-A4-NeuroP	3-((1S,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010427	13-epi-13-A4-NeuroP	(R,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010428	ent-16-epi-13-A4-NeuroP	(R,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010429	13,16-diepi-13-A4-NeuroP	(R,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010430	ent-13-A4-NeuroP	(R,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010431	13-A4-NeuroP	(S,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010432	ent-13,16-diepi-13-A4-NeuroP	(S,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010433	16-epi-13-A4-NeuroP	(S,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010434	ent-13-epi-13-A4-NeuroP	(S,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010435	14-epi-14-A4-NeuroP	(Z)-6-((1R,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04010436	ent-7-epi-14-A4-NeuroP	(Z)-6-((1R,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid	FA 22:7;O2	C22H30O4	358.214410
LMFA04050003	(7S)-Maresin 1	7S,14S-dihydroxy-4Z,8E,10E,12E,16Z,19Z-docosahexaenoic acid	FA 22:6;O2	C22H32O4	360.230060
LMFA04000091	Resolvin T1	7,13,20-Trihydroxy-8E,10Z,14E,16Z,18E-docosapentaenoic acid	FA 22:5;O3	C22H34O5	378.240625
LMFA04000092	Resolvin T2	7,8,13-Trihydroxy-9E,11E,13E,15Z,19Z-docosapentaenoic acid	FA 22:5;O3	C22H34O5	378.240625
LMFA04000093	Resolvin T3	7,12,13-Trihydroxy-8Z,10E,14E,16Z,19Z-docosapentaenoic acid	FA 22:5;O3	C22H34O5	378.240625
LMFA04000094	Resolvin T4	7,13-Dihydroxy-8E,10Z,14E,16Z,19Z-docosapentaenoic acid	FA 22:5;O2	C22H34O4	362.245710
LMFA04050001	Maresin 1	7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic acid	FA 22:6;O2	C22H32O4	360.230060
LMFA04050004	Maresin 2	13R,14S-dihydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid	FA 22:6;O2	C22H32O4	360.230060
LMFA04030013	Resolvin D6i	4R,17R-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid	FA 22:6;O2	C22H32O4	360.230060
LMFA04000095	Cymatherol C	9-[(1R,2S,3S,5S)-3-[(1S,2R)-2-[(1R)-1-Hydroxypropyl]cyclopropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]nona-5Z,8Z-dienoic acid	FA 20:5;O2	C20H30O4	334.214410
LMFA04050006	MCTR2	13R-(S-cysteinylglycinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid		C27H40N2O6S	520.260710
LMFA04050007	MCTR3	13R-(S-cysteinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid		C25H37NO5S	463.239246

LM_ID

Common Name

Systematic Name

Species Shorthand

Formula

Mass

LMFA04010398

ent-4-A4-NeuroP

(R,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010399

4-A4-NeuroP

(S,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010400

ent-4,7-diepi-4-A4-NeuroP

(S,E)-4-hydroxy-6-((1R,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010401

7-epi-4-A4-NeuroP

(S,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010402

ent-4-epi-4-A4-NeuroP

(S,E)-4-hydroxy-6-((1S,5S)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010403

7-epi-7-A4-NeuroP

(R,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010404

ent-10-epi-7-A4-NeuroP

(R,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010405

7,10-diepi-7-A4-NeuroP

(R,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010406

ent-7-A4-NeuroP

(R,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010407

7-A4-NeuroP

(S,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010408

ent-7,10-diepi-7-A4-NeuroP

(S,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010409

10-epi-7-A4-NeuroP

(S,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010410

ent-7-epi-7-A4-NeuroP

(S,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010411

10-epi-10-A4-NeuroP

(R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010412

ent-13-epi-10-A4-NeuroP

(R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010413

10,13-diepi-10-A4-NeuroP

(R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010414

ent-10-A4-NeuroP

(R,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010415

10-A4-NeuroP

(S,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010416

ent-10,13-diepi-10-A4-NeuroP

(S,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010417

13-epi-10-A4-NeuroP

(S,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010418

ent-10-epi-10-A4-NeuroP

(S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010419

11-epi-11-A4-NeuroP

3-((1R,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010420

ent-4-epi-11-A4-NeuroP

3-((1R,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010421

4,11-diepi-11-A4-NeuroP

3-((1S,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010422

ent-11-A4-NeuroP

3-((1S,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010423

11-A4-NeuroP

3-((1R,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010424

ent-4,11-diepi-11-A4-NeuroP

3-((1R,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010425

4-epi-11-A4-NeuroP

3-((1S,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010426

ent-11-epi-11-A4-NeuroP

3-((1S,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010427

13-epi-13-A4-NeuroP

(R,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010428

ent-16-epi-13-A4-NeuroP

(R,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010429

13,16-diepi-13-A4-NeuroP

(R,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010430

ent-13-A4-NeuroP

(R,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010431

13-A4-NeuroP

(S,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010432

ent-13,16-diepi-13-A4-NeuroP

(S,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010433

16-epi-13-A4-NeuroP

(S,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010434

ent-13-epi-13-A4-NeuroP

(S,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010435

14-epi-14-A4-NeuroP

(Z)-6-((1R,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04010436

ent-7-epi-14-A4-NeuroP

(Z)-6-((1R,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid

FA 22:7;O2

C22H30O4

358.214410

LMFA04050003

(7S)-Maresin 1

7S,14S-dihydroxy-4Z,8E,10E,12E,16Z,19Z-docosahexaenoic acid

FA 22:6;O2

C22H32O4

360.230060

LMFA04000091

Resolvin T1

7,13,20-Trihydroxy-8E,10Z,14E,16Z,18E-docosapentaenoic acid

FA 22:5;O3

C22H34O5

378.240625

LMFA04000092

Resolvin T2

7,8,13-Trihydroxy-9E,11E,13E,15Z,19Z-docosapentaenoic acid

FA 22:5;O3

C22H34O5

378.240625

LMFA04000093

Resolvin T3

7,12,13-Trihydroxy-8Z,10E,14E,16Z,19Z-docosapentaenoic acid

FA 22:5;O3

C22H34O5

378.240625

LMFA04000094

Resolvin T4

7,13-Dihydroxy-8E,10Z,14E,16Z,19Z-docosapentaenoic acid

FA 22:5;O2

C22H34O4

362.245710

LMFA04050001

Maresin 1

7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic acid

FA 22:6;O2

C22H32O4

360.230060

LMFA04050004

Maresin 2

13R,14S-dihydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid

FA 22:6;O2

C22H32O4

360.230060

LMFA04030013

Resolvin D6i

4R,17R-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid

FA 22:6;O2

C22H32O4

360.230060

LMFA04000095

Cymatherol C

9-[(1R,2S,3S,5S)-3-[(1S,2R)-2-[(1R)-1-Hydroxypropyl]cyclopropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]nona-5Z,8Z-dienoic acid

FA 20:5;O2

C20H30O4

334.214410

LMFA04050006

MCTR2

13R-(S-cysteinylglycinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid

C27H40N2O6S

520.260710

LMFA04050007

MCTR3

13R-(S-cysteinyl)-14S-hydroxy-4Z,7Z,9E,11E,16Z,19Z-docosahexaenoic acid

C25H37NO5S

463.239246

Structure Database (LMSD)

LMSD: Lipid classification search results

Docosanoids [FA04]